Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INDIEH: Epinephrine Spray and Rectal Indomethacin for PEP Prevention
NCT02116309Completed
- Sponsor
- Johns Hopkins University
- Start
- Aug 2014
- Primary completion
- Dec 2016
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 2
01
Overview
Randomised, double-blind trial of epinephrine in post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP), sponsored by Johns Hopkins University. Primary endpoint: Post-ERCP Pancreatitis at 24 hours. Started Aug 2014; status: completed.
02
Drugs
epinephrine
03
Conditions
post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP)
Beyond the preview
Go deeper on NCT02116309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02116309.